Allogenic NK Cell Transfusion Azacitidine MDS-EB
Clinical trial NCT04599426 · UNKNOWN
Trial details
- NCT number
- NCT04599426
- Sponsor
- The Second Hospital of Shandong University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2023-12-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.